The Enhanced Tumorigenic Activity of a Mutant Epidermal Growth Factor Receptor Common in Human Cancers Is Mediated by Threshold Levels of Constitutive Tyrosine Phosphorylation and Unattenuated Signaling

0301 basic medicine Base Sequence Epidermal Growth Factor Brain Neoplasms Molecular Sequence Data Down-Regulation Mice, Nude Endocytosis Peptide Fragments Recombinant Proteins Cell Line 3. Good health ErbB Receptors Mice 03 medical and health sciences Mutagenesis, Site-Directed Animals Humans Amino Acid Sequence Phosphorylation Glioblastoma Phosphotyrosine DNA Primers
DOI: 10.1074/jbc.272.5.2927 Publication Date: 2002-07-26T14:57:46Z
ABSTRACT
Deregulation of signaling by the epidermal growth factor receptor (EGFR) is common in human malignancy progression. One mutant EGFR (variously named ΔEGFR, de2-7 EGFR, or EGFRvIII), which occurs frequently cancers, lacks a portion extracellular ligand-binding domain due to genomic deletions that eliminate exons 2 7 and confers dramatic enhancement brain tumor cell tumorigenicity <i>in vivo</i>. In order dissect molecular mechanisms this activity, we analyzed location, autophosphorylation, attenuation receptors. The receptors were expressed on surface constitutively autophosphorylated at significantly decreased level compared with wild-type activated ligand treatment. Unlike active ΔEGFR not down-regulated, suggesting altered conformation did result exposure sequence motifs required for endocytosis lysosomal sorting. Mutational analysis showed enhanced was dependent intrinsic tyrosine kinase activity mediated through carboxyl terminus. contrast receptor, mutation any major autophosphorylation site abolished these activities biological functions are low constitutive activation mitogenic effects amplified failure attenuate down-regulation.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (72)
CITATIONS (457)